- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Norris Medicines Limited's Board has approved the financial results for the quarter and year ended March 31, 2026, which received an unmodified audit opinion, providing clarity on the company's recent performance. Additionally, the Board appointed M/s. Dhiren Y Parikh & Co., Chartered Accountants, as Internal Auditors for FY 2026-2027. This appointment aims to strengthen the company’s internal control systems and enhance transparency and accountability for shareholders.